Michael H. Davidson
Chief Executive Officer, Director · NewAmsterdam Pharma Co N.V.
- 2024
- Sep 15, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Michael H. Davidson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Louise Frederika Kooij - $16.75M in NAMS purchases and sales in the last 12 months
- Johannes Jacob Pieter Kastelein - $15.52M in NAMS purchases and sales in the last 12 months
- Mayur Ian Somaiya - $3.43M in NAMS purchases and sales in the last 12 months
- Louis G. Lange - $2.19M in NAMS purchases and sales in the last 12 months
- John W. Smither - $41K in NAMS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michael H. Davidson?
Michael H. Davidson is a corporate insider, tracked as Chief Executive Officer, Director of NewAmsterdam Pharma Co N.V. (NAMS). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Michael H. Davidson submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Michael H. Davidson been buying or selling stock?
Recorded transactions: 1 open-market purchase ($226K) and 9 open-market sales ($25.33M) across all tracked filings.
